Kok Hooi Lim
About Kok Hooi Lim
Kok Hooi Lim is a Senior Quality Manager at Boston Scientific in Penang, Malaysia, with extensive experience in quality management and engineering across various industries.
Current Role at Boston Scientific
Kok Hooi Lim has been serving as the Senior Quality Manager at Boston Scientific since 2016. Based in Penang, Malaysia, he oversees various quality management processes and has spearheaded multiple successful initiatives, including the remediation of the Lotus edge heart valve product manufacturing processes. His role also involves ensuring compliance with regulatory standards and maintaining high-quality manufacturing practices.
Previous Experience at St. Jude Medical
From 2011 to 2016, Kok Hooi Lim worked at St. Jude Medical as the Quality Engineering Section Head in Penang, Malaysia. During his tenure, he was responsible for leading the quality engineering section and implementing key quality control measures. His experience at St. Jude Medical laid a strong foundation for his subsequent roles in the medical device industry.
Educational Background
Kok Hooi Lim holds an MBA in Service Science Management and Engineering from Universiti Sains Malaysia, completed between 2017 and 2021. He also earned a Bachelor of Science degree in Microbiology from the same university, graduating in 2005. His academic background has provided him with a strong foundation in both scientific principles and business management, which are crucial for his roles in quality management.
Career Beginnings
Kok Hooi Lim began his career at Kerry Group as a Quality Engineer from 2005 to 2010. He then moved to Gold Choice Food Industries as a Quality Executive for 11 months in 2010 before joining St. Jude Medical. These early roles helped him develop a robust understanding of quality control processes across different industries, which he has carried into his subsequent positions in the medical device field.
Notable Projects and Achievements
Kok Hooi Lim has led several significant projects throughout his career. In 2017, he successfully remediated the Lotus edge heart valve product manufacturing processes. The following year, he completed the transfer of heart valve manufacturing to Penang, achieving compliance with regulatory standards and passing the FDA's pre-market approval inspection. Other notable achievements include managing the transfer of tissue fixation manufacturing to Penang in 2019, overseeing the transfer of Braid manufacturing in 2020, and completing the Balloon Dilatation Catheter manufacturing transfer to Penang in 2021. He also organized a customer satisfaction forum to leverage customer complaint data for continuous improvement.